Literature DB >> 10646886

Vascular grading of angiogenesis: prognostic significance in breast cancer.

S Hansen1, D A Grabau, F B Sørensen, M Bak, W Vach, C Rose.   

Abstract

The study aimed to evaluate the prognostic value of angiogenesis by vascular grading of primary breast tumours, and to evaluate the prognostic impact of adding the vascular grade to the Nottingham Prognostic Index (NPI). The investigation included 836 patients. The median follow-up time was 11 years and 4 months. The microvessels were immunohistochemically stained by antibodies against CD34. Angiogenesis was graded semiquantitatively by subjective scoring into three groups according to the expected number of microvessels in the most vascular tumour area. The vascular grading between observers was moderately reproduced (kappa = 0.59). Vascular grade was significantly associated with axillary node involvement, tumour size, malignancy grade, oestrogen receptor status and histological type. In univariate analyses vascular grade significantly predicted recurrence free survival and overall survival for all patients (P < 0.0001), node-negative patients (P < 0.0001) and node-positive patients (P < 0.0001). Cox multivariate regression analysis showed that vascular grading contributed with independent prognostic value in all patients (P < 0.0001). A prognostic index including the vascular grade had clinical impact for 24% of the patients, who had a shift in prognostic group, as compared to NPI, and implied a better prognostic dissemination. We concluded that the angiogenesis determined by vascular grading has independent prognostic value of clinical relevance for patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10646886      PMCID: PMC2363269          DOI: 10.1054/bjoc.1999.0924

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival.

Authors:  A Obermair; C Kurz; K Czerwenka; M Thoma; A Kaider; T Wagner; G Gitsch; P Sevelda
Journal:  Int J Cancer       Date:  1995-07-17       Impact factor: 7.396

2.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

3.  Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.

Authors:  K Axelsson; B M Ljung; D H Moore; A D Thor; K L Chew; S M Edgerton; H S Smith; B H Mayall
Journal:  J Natl Cancer Inst       Date:  1995-07-05       Impact factor: 13.506

4.  Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma.

Authors:  M Toi; J Kashitani; T Tominaga
Journal:  Int J Cancer       Date:  1993-09-30       Impact factor: 7.396

5.  Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression.

Authors:  M Toi; K Inada; H Suzuki; T Tominaga
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Is the relationship between angiogenesis and metastasis in breast cancer real?

Authors:  N R Hall; D E Fish; N Hunt; R D Goldin; P J Guillou; J R Monson
Journal:  Surg Oncol       Date:  1992-06       Impact factor: 3.279

7.  The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  I Balslev; C K Axelsson; K Zedeler; B B Rasmussen; B Carstensen; H T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer.

Authors:  G Gasparini; M Barbareschi; P Boracchi; P Bevilacqua; P Verderio; P Dalla Palma; S Ménard
Journal:  Int J Cancer       Date:  1995-03-03       Impact factor: 7.396

9.  [Tumoral vascular density in breast tumors and their effect on recurrence-free survival].

Authors:  A Obermair; K Czerwenka; C Kurz; A Kaider; P Sevelda
Journal:  Chirurg       Date:  1994-07       Impact factor: 0.955

10.  Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen.

Authors:  Y Ogawa; Y S Chung; B Nakata; S Takatsuka; K Maeda; T Sawada; Y Kato; K Yoshikawa; M Sakurai; M Sowa
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

View more
  17 in total

1.  Diffusion weighted MRI and spectroscopy in invasive carcinoma of the breast at 3Tesla. Correlation with dynamic contrast enhancement and pathologic findings.

Authors:  G Boulogianni; I Chryssogonidis; A Drevelegas
Journal:  Hippokratia       Date:  2016 Jul-Sep       Impact factor: 0.471

2.  Computerized three-class classification of MRI-based prognostic markers for breast cancer.

Authors:  Neha Bhooshan; Maryellen Giger; Darrin Edwards; Yading Yuan; Sanaz Jansen; Hui Li; Li Lan; Husain Sattar; Gillian Newstead
Journal:  Phys Med Biol       Date:  2011-08-22       Impact factor: 3.609

3.  Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index.

Authors:  M Tenderenda; P Rutkowski; D Jesionek-Kupnicka; R Kubiak
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

4.  What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?

Authors:  R Arisio; A Sapino; P Cassoni; G Accinelli; M C Cuccorese; M P Mano; G Bussolati
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

5.  Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival.

Authors:  Hong-Qing Xi; Xiao-Song Wu; Bo Wei; Lin Chen
Journal:  J Gastroenterol       Date:  2012-02-17       Impact factor: 7.527

6.  The determination of VEGF and MVD, among patients with primary breast cancer.

Authors:  Anna Thielemann; Zygmunt Kopczyński; Violetta Filas; Jan Breborowicz; Sylwia Grodecka-Gazdecka; Aleksandra Baszczuk
Journal:  Pathol Oncol Res       Date:  2008-04-09       Impact factor: 3.201

7.  Feasibility of near-infrared diffuse optical spectroscopy on patients undergoing imageguided core-needle biopsy.

Authors:  Bing Yu; Elizabeth S Burnside; Gale A Sisney; Josephine M Harter; Changfang Zhu; Al-Hafeez Dhalla; Nirmala Ramanujam
Journal:  Opt Express       Date:  2007-06-11       Impact factor: 3.894

8.  Y-box binding protein 1 expression in gastric cancer subtypes and association with cancer neovasculature.

Authors:  Y Wu; K-Y Wang; Z Li; Y-P Liu; H Izumi; S Yamada; H Uramoto; Y Nakayama; K Ito; K Kohno
Journal:  Clin Transl Oncol       Date:  2014-07-31       Impact factor: 3.405

9.  Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.

Authors:  Shioto Suzuki; Yoh Dobashi; Yayoi Hatakeyama; Ryosuke Tajiri; Takashi Fujimura; Carl H Heldin; Akishi Ooi
Journal:  BMC Cancer       Date:  2010-11-30       Impact factor: 4.430

10.  VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.

Authors:  Concetta Saponaro; Andrea Malfettone; Girolamo Ranieri; Katia Danza; Giovanni Simone; Angelo Paradiso; Anita Mangia
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.